MBIO (MBIO) Stock Price & Analysis
MBIO (MBIO) fell 3.19% to USD 0.54 as of September 8, 2026 at 09:04 UTC, according to Nexqual real-time market data.
MBIO last closed at USD 0.54; the session ranged USD 0.53–0.56 on volume of 37,376 shares. Market capitalization is —, with a 52-week range of USD 0.53–1.85 (NCM). Source: Nexqual, September 8, 2026 at 09:04 UTC.
Key Statistics (as of September 8, 2026 at 09:04 UTC)
| Price | USD 0.54 |
|---|---|
| Change | ▼ 3.19% (down) |
| Previous Close | USD 0.54 |
| Open | USD 0.54 |
| Day Range | USD 0.53 – 0.56 |
| 52-Week Range | USD 0.53 – 1.85 |
| Volume | 37,376 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (MBIO)
Nexqual's technical model rates MBIO "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.87 (neutral) |
| vs SMA50 | Below (USD 0.61) |
| MACD | -0.02 (negative) |
From MBIO's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FBIO | Fortress Biotech, Inc. | USD 2.72 | ▼ 0.37% |
| NDRA | ENDRA Life Sciences Inc. | USD 6.05 | ▼ 6.35% |
| PTN | Palatin Technologies, Inc. | USD 12.7 | ▼ 1.09% |
| NCNA | NuCana plc | USD 1.4 | ▲ 0.72% |
| DARE | Dare Bioscience, Inc. | USD 0.72 | ▼ 2.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:04 UTC. This page is informational and not investment advice.